Jiang W - Search Results

1

Antihistamine Drug Ebastine Inhibits Cancer Growth by Targeting Polycomb Group Protein EZH2.

Li Q, Liu KY, Liu Q, Wang G, Jiang W, Meng Q, Yi Y, Yang Y, Wang R, Zhu S, Li C, Wu L, Zhao D, Yan L, Zhang L, Kim JS, Zu X, Kozielski AJ, Qian W, Chang JC, Patnaik A, Chen K, Cao Q. Li Q, et al. Among authors: jiang w. Mol Cancer Ther. 2020 Oct;19(10):2023-2033. doi: 10.1158/1535-7163.MCT-20-0250. Epub 2020 Aug 27. Mol Cancer Ther. 2020. PMID: 32855270 Free PMC article.

2

BMI1 regulates androgen receptor in prostate cancer independently of the polycomb repressive complex 1.

Zhu S, Zhao D, Yan L, Jiang W, Kim JS, Gu B, Liu Q, Wang R, Xia B, Zhao JC, Song G, Mi W, Wang RF, Shi X, Lam HM, Dong X, Yu J, Chen K, Cao Q. Zhu S, et al. Among authors: jiang w. Nat Commun. 2018 Feb 5;9(1):500. doi: 10.1038/s41467-018-02863-3. Nat Commun. 2018. PMID: 29402932 Free PMC article.

3

Polycomb group proteins EZH2 and EED directly regulate androgen receptor in advanced prostate cancer.

Liu Q, Wang G, Li Q, Jiang W, Kim JS, Wang R, Zhu S, Wang X, Yan L, Yi Y, Zhang L, Meng Q, Li C, Zhao D, Qiao Y, Li Y, Gursel DB, Chinnaiyan AM, Chen K, Cao Q. Liu Q, et al. Among authors: jiang w. Int J Cancer. 2019 Jul 15;145(2):415-426. doi: 10.1002/ijc.32118. Epub 2019 Feb 12. Int J Cancer. 2019. PMID: 30628724 Free PMC article.

4

BMI1 is directly regulated by androgen receptor to promote castration-resistance in prostate cancer.

Zhu S, Zhao D, Li C, Li Q, Jiang W, Liu Q, Wang R, Fazli L, Li Y, Zhang L, Yi Y, Meng Q, Wang W, Wang G, Zhang M, Zu X, Zhao W, Deng T, Yu J, Dong X, Chen K, Cao Q. Zhu S, et al. Among authors: jiang w. Oncogene. 2020 Jan;39(1):17-29. doi: 10.1038/s41388-019-0966-4. Epub 2019 Aug 28. Oncogene. 2020. PMID: 31462713 Free PMC article.

5

A PRC2-independent function for EZH2 in regulating rRNA 2'-O methylation and IRES-dependent translation.

Yi Y, Li Y, Meng Q, Li Q, Li F, Lu B, Shen J, Fazli L, Zhao D, Li C, Jiang W, Wang R, Liu Q, Szczepanski A, Li Q, Qin W, Weiner AB, Lotan TL, Ji Z, Kalantry S, Wang L, Schaeffer EM, Niu H, Dong X, Zhao W, Chen K, Cao Q. Yi Y, et al. Among authors: jiang w. Nat Cell Biol. 2021 Apr;23(4):341-354. doi: 10.1038/s41556-021-00653-6. Epub 2021 Apr 1. Nat Cell Biol. 2021. PMID: 33795875 Free PMC article.

6

CHD6 promotes broad nucleosome eviction for transcriptional activation in prostate cancer cells.

Zhao D, Zhang M, Huang S, Liu Q, Zhu S, Li Y, Jiang W, Kiss DL, Cao Q, Zhang L, Chen K. Zhao D, et al. Among authors: jiang w. Nucleic Acids Res. 2022 Nov 28;50(21):12186-12201. doi: 10.1093/nar/gkac1090. Nucleic Acids Res. 2022. PMID: 36408932 Free PMC article.

7

The novel BH3 α-helix mimetic JY-1-106 induces apoptosis in a subset of cancer cells (lung cancer, colon cancer and mesothelioma) by disrupting Bcl-xL and Mcl-1 protein-protein interactions with Bak.

Cao X, Yap JL, Newell-Rogers MK, Peddaboina C, Jiang W, Papaconstantinou HT, Jupitor D, Rai A, Jung KY, Tubin RP, Yu W, Vanommeslaeghe K, Wilder PT, MacKerell AD Jr, Fletcher S, Smythe RW. Cao X, et al. Among authors: jiang w. Mol Cancer. 2013 May 16;12(1):42. doi: 10.1186/1476-4598-12-42. Mol Cancer. 2013. PMID: 23680104 Free PMC article.

8

Interleukin-21 receptor signaling promotes metabolic dysfunction-associated steatohepatitis-driven hepatocellular carcinoma by inducing immunosuppressive IgA⁺ B cells.

Xie Y, Huang Y, Li ZY, Jiang W, Shi NX, Lu Y, Cao G, Yin Z, Lin XJ. Xie Y, et al. Among authors: jiang w. Mol Cancer. 2024 May 8;23(1):95. doi: 10.1186/s12943-024-02001-2. Mol Cancer. 2024. PMID: 38720319 Free PMC article.

9

The downregulation of Mcl-1 via USP9X inhibition sensitizes solid tumors to Bcl-xl inhibition.

Peddaboina C, Jupiter D, Fletcher S, Yap JL, Rai A, Tobin RP, Jiang W, Rascoe P, Rogers MK, Smythe WR, Cao X. Peddaboina C, et al. Among authors: jiang w. BMC Cancer. 2012 Nov 21;12:541. doi: 10.1186/1471-2407-12-541. BMC Cancer. 2012. PMID: 23171055 Free PMC article.

10

Ras GTPase-Activating-Like Protein IQGAP1 (IQGAP1) Promotes Breast Cancer Proliferation and Invasion and Correlates with Poor Clinical Outcomes.

Zeng F, Jiang W, Zhao W, Fan Y, Zhu Y, Zhang H. Zeng F, et al. Among authors: jiang w. Med Sci Monit. 2018 May 20;24:3315-3323. doi: 10.12659/MSM.909916. Med Sci Monit. 2018. PMID: 29779034 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

16,189 results

Search Page